Terms: = Kidney tumors AND B2M, P61769, 567, ENSG00000166710
48 results:
1. Surgical management of Rathke cleft cysts in pediatric patients: a single institution experience.
Brandel MG; Lin C; Rennert RC; Plonsker JH; Khan UA; Crawford JR; Nation J; Levy ML
Childs Nerv Syst; 2024 May; 40(5):1367-1375. PubMed ID: 38240786
[TBL] [Abstract] [Full Text] [Related]
2. Hospitalizations Among Veterans Treated for Metastatic Prostate Cancer With Abiraterone or Enzalutamide.
Riekhof F; Yan Y; Bennett CL; Sanfilippo KM; Carson KR; Chang SH; Georgantopoulos P; Luo S; Govindan S; Cheranda N; Afzal A; Schoen MW
Clin Genitourin Cancer; 2024 Apr; 22(2):18-26.e3. PubMed ID: 37495480
[TBL] [Abstract] [Full Text] [Related]
3. Gallstones, Cholecystectomy, and kidney Cancer: Observational and Mendelian Randomization Results Based on Large Cohorts.
Kharazmi E; Scherer D; Boekstegers F; Liang Q; Sundquist K; Sundquist J; Fallah M; Lorenzo Bermejo J
Gastroenterology; 2023 Jul; 165(1):218-227.e8. PubMed ID: 37054756
[TBL] [Abstract] [Full Text] [Related]
4. Inhibition of FGFR Reactivates IFNγ Signaling in Tumor Cells to Enhance the Combined Antitumor Activity of Lenvatinib with Anti-PD-1 Antibodies.
Adachi Y; Kamiyama H; Ichikawa K; Fukushima S; Ozawa Y; Yamaguchi S; Goda S; Kimura T; Kodama K; Matsuki M; Miyano SW; Yokoi A; Kato Y; Funahashi Y
Cancer Res; 2022 Jan; 82(2):292-306. PubMed ID: 34753772
[TBL] [Abstract] [Full Text] [Related]
5. Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial.
Tang C; Msaouel P; Hara K; Choi H; Le V; Shah AY; Wang J; Jonasch E; Choi S; Nguyen QN; Das P; Prajapati S; Yu Z; Khan K; Powell S; Murthy R; Sircar K; Tannir NM
Lancet Oncol; 2021 Dec; 22(12):1732-1739. PubMed ID: 34717797
[TBL] [Abstract] [Full Text] [Related]
6. Incidence of suicide mortality among childhood cancer survivors: A population-based retrospective study.
Fu XL; Wu H; Qian Y; Jin XH; Yu HR; Du L; Chen HL; Shi YQ
Psychiatry Res; 2021 Oct; 304():114119. PubMed ID: 34325189
[TBL] [Abstract] [Full Text] [Related]
7. A novel circRNA, circNUP98, a potential biomarker, acted as an oncogene via the miR-567/ PRDX3 axis in renal cell carcinoma.
Yu R; Yao J; Ren Y
J Cell Mol Med; 2020 Sep; 24(17):10177-10188. PubMed ID: 32729669
[TBL] [Abstract] [Full Text] [Related]
8. Shrunken pore syndrome and mortality: a cohort study of patients with measured GFR and known comorbidities.
Åkesson A; Lindström V; Nyman U; Jonsson M; Abrahamson M; Christensson A; Björk J; Grubb A
Scand J Clin Lab Invest; 2020 Sep; 80(5):412-422. PubMed ID: 32459111
[TBL] [Abstract] [Full Text] [Related]
9. Development and validation of an individualized DNA repair-related gene signature in localized clear cell renal cell carcinoma.
Xiong Y; Qi Y; Lin W; Bai Q; Liu L; Guo J
World J Urol; 2021 Apr; 39(4):1203-1210. PubMed ID: 32458095
[TBL] [Abstract] [Full Text] [Related]
10. Abundant CD8+ tumor infiltrating lymphocytes and beta-2-microglobulin are associated with better outcome and response to interleukin-2 therapy in advanced stage clear cell renal cell carcinoma.
Davis D; Tretiakova MS; Kizzar C; Woltjer R; Krajbich V; Tykodi SS; Lanciault C; Andeen NK
Ann Diagn Pathol; 2020 Aug; 47():151537. PubMed ID: 32454441
[TBL] [Abstract] [Full Text] [Related]
11. TFEB Expression Profiling in Renal Cell Carcinomas: Clinicopathologic Correlations.
Gupta S; Argani P; Jungbluth AA; Chen YB; Tickoo SK; Fine SW; Gopalan A; Al-Ahmadie HA; Sirintrapun SJ; Sanchez A; Hakimi AA; Mcfarlane T; Salazar PA; Williamson SR; Skala SL; Mehra R; Hes O; Antonescu CR; Ladanyi M; Arcila ME; Reuter VE
Am J Surg Pathol; 2019 Nov; 43(11):1445-1461. PubMed ID: 31600176
[TBL] [Abstract] [Full Text] [Related]
12. A large-scale transcriptome analysis identified ELANE and PRTN3 as novel methylation prognostic signatures for clear cell renal cell carcinoma.
Wei Z; Wu B; Wang L; Zhang J
J Cell Physiol; 2020 Mar; 235(3):2582-2589. PubMed ID: 31490025
[TBL] [Abstract] [Full Text] [Related]
13. Robot-assisted Level III-IV Inferior Vena Cava Thrombectomy: Initial Series with Step-by-step Procedures and 1-yr Outcomes.
Wang B; Huang Q; Liu K; Fan Y; Peng C; Gu L; Shi T; Zhang P; Chen W; Du S; Niu S; Liu R; Zhao G; Li Q; Xiao C; Wang R; Li S; Wang M; Liu F; Wang H; Li H; Ma X; Zhang X
Eur Urol; 2020 Jul; 78(1):77-86. PubMed ID: 31103390
[TBL] [Abstract] [Full Text] [Related]
14. Outcomes of nonmetastatic micropapillary variant upper tract urothelial carcinoma.
Duplisea JJ; Petros FG; Li R; Fellman B; Guo CC; Czerniak BA; Siefker-Radtke AO; Araujo JC; Dinney CPN; Matin SF
Urol Oncol; 2019 Jun; 37(6):354.e19-354.e26. PubMed ID: 30777393
[TBL] [Abstract] [Full Text] [Related]
15. Total HLA Class I Antigen Loss with the Downregulation of Antigen-Processing Machinery Components in Two Newly Established Sarcomatoid Hepatocellular Carcinoma Cell Lines.
Lei WY; Hsiung SC; Wen SH; Hsieh CH; Chen CL; Wallace CG; Chang CC; Liao SK
J Immunol Res; 2018; 2018():8363265. PubMed ID: 30648121
[TBL] [Abstract] [Full Text] [Related]
16. Evaluation of Urinary Renal Biomarkers for Early Prediction of Acute kidney Injury Following Partial Nephrectomy: A Feasibility Study.
Lane BR; Babitz SK; Vlasakova K; Wong A; Noyes SL; Boshoven W; Grady P; Zimmerman C; Engerman S; Gebben M; Tanen M; Glaab WE; Sistare FD
Eur Urol Focus; 2020 Nov; 6(6):1240-1247. PubMed ID: 30425001
[TBL] [Abstract] [Full Text] [Related]
17. Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.
Voss MH; Reising A; Cheng Y; Patel P; Marker M; Kuo F; Chan TA; Choueiri TK; Hsieh JJ; Hakimi AA; Motzer RJ
Lancet Oncol; 2018 Dec; 19(12):1688-1698. PubMed ID: 30416077
[TBL] [Abstract] [Full Text] [Related]
18. Efficacy and Safety of Microwave Ablation for Malignant Renal tumors: An Updated Systematic Review and Meta-Analysis of the Literature Since 2012.
Choi SH; Kim JW; Kim JH; Kim KW
Korean J Radiol; 2018; 19(5):938-949. PubMed ID: 30174484
[TBL] [Abstract] [Full Text] [Related]
19. Does urinary cytology have a role in haematuria investigations?
Tan WS; Sarpong R; Khetrapal P; Rodney S; Mostafid H; Cresswell J; Watson D; Rane A; Hicks J; Hellawell G; Davies M; Srirangam SJ; Dawson L; Payne D; Williams N; Brew-Graves C; Feber A; Kelly JD;
BJU Int; 2019 Jan; 123(1):74-81. PubMed ID: 30003675
[TBL] [Abstract] [Full Text] [Related]
20. Salvage topical therapy for upper tract urothelial carcinoma.
Balasubramanian A; Metcalfe MJ; Wagenheim G; Xiao L; Papadopoulos J; Navai N; Davis JW; Karam JA; Kamat AM; Wood CG; Dinney CP; Matin SF
World J Urol; 2018 Dec; 36(12):2027-2034. PubMed ID: 29804202
[TBL] [Abstract] [Full Text] [Related]
[Next]
